We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$418M
AUM Growth
-$30.8M
Cap. Flow
-$37.5M
Cap. Flow %
-8.97%
Top 10 Hldgs %
54.35%
Holding
163
New
44
Increased
31
Reduced
48
Closed
39

Sector Composition

Rank Sector Weight
1 Financials 9.06%
2 Industrials 7.6%
3 Materials 7.59%
4 Consumer Discretionary 5.8%
5 Healthcare 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLO icon
151
Valero Energy
VLO
$85.9B
-10,776
Closed -$771K
VYX icon
152
NCR Voyix
VYX
$1.14B
-47,215
Closed -$1.1M
WFC icon
153
Wells Fargo
WFC
$264B
-78,930
Closed -$3.08M
WW
154
DELISTED
WW International
WW
-6,352
Closed -$199K
ZD icon
155
Ziff Davis
ZD
$1.98B
-18,313
Closed -$1.91M
ZEUS
156
DELISTED
Olympic Steel
ZEUS
-16,341
Closed -$481K
EQC
157
DELISTED
Equity Commonwealth
EQC
-90,521
Closed -$2.52M
SFE
158
DELISTED
Safeguard Scientifics, Inc.
SFE
-64,563
Closed -$440K
TEN
159
CALL
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-7,700
Closed -$83K
HWCC
160
DELISTED
Houston Wire & Cable Company
HWCC
-408,473
Closed -$2.13M
SRAX
161
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
-16,483
Closed -$78K
GRA
162
DELISTED
W.R. Grace & Co.
GRA
-26,738
Closed -$1.6M
TYNS
163
PUT
DELISTED
Direxion Daily 7-10 Year Treasury Bear 1X Shares
TYNS
-53,700
Closed -$4.13M

Similar funds

Invenomic Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Invenomic Capital Management held 163 positions worth $418M, down 6.9% from $448M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Invenomic Capital Management withdrew a net $37.5M in Q2 2021, closing 39 positions and reducing 48 holdings. Its most notable exit was UGI, an estimated $3.26M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.1% of assets, up from 6.9% a quarter earlier, followed by Industrials and Materials.

Against the trend, Invenomic Capital Management opened a new position in Popular Inc worth $3.23M.

  • Invenomic Capital Management's largest Q2 2021 buy was Popular Inc: 43,078 shares worth $3.23M.
  • Invenomic Capital Management added most to Surgalign Holdings, Inc. Common Stock in Q2 2021, an estimated $3.75M increase.
  • Invenomic Capital Management's biggest Q2 2021 reduction was Molson Coors Class B, cutting an estimated $3.57M.
  • Invenomic Capital Management fully exited UGI in Q2 2021, selling an estimated $3.26M.
  • Invenomic Capital Management's ten largest holdings make up 54% of its $418M portfolio in Q2 2021.
  • Invenomic Capital Management opened 44 new positions and closed 39 in Q2 2021.
  • Invenomic Capital Management's portfolio value fell 6.9% quarter-over-quarter to $418M.

Based on Invenomic Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.